Apoptosis Research Uncovers Potential Therapeutic Option for Cancer Treatment
Researchers at the University of Lahore have made significant findings in the study of apoptosis, a process of programmed cell death that plays a crucial role in cancer development and progression. According to a new report, the secretome from umbilical cord mesenchymal stem cells (UCMSCs) has been shown to inhibit the growth of prostate and cervical cancer cells, inducing apoptosis and reducing proliferation. The study highlights the potential of UCMSCs-Sec as a therapeutic strategy for the treatment of neoplastic cells.
Key Takeaways:
- The secretome from umbilical cord mesenchymal stem cells (UCMSCs) has been found to inhibit the growth of prostate and cervical cancer cells, inducing apoptosis.
- Gene expression analysis showed that apoptotic genes (BAX and caspase-3) were upregulated, while proliferative genes (ki67 and PCNA) were reduced.
- The UCMSCs-Sec treatment was also found to reduce neovascularization in cancer cells.
- Relative levels of secreted antioxidative enzymes were also reduced in PC-3 and HeLa cells treated with UCMSCs-Sec.
- The study suggests that UCMSCs-Sec may promote cellular death and prevent the cellular division of cancer cells.
- The anticancer potential of secretome from UCMSCs could be a viable therapeutic option for the treatment of neoplastic cells.
- Researchers used cell viability assay, ELISA for vascular endothelial growth factor (VEGF), and RT-PCR to measure gene expression levels.
Statistics:
- 7 days: The duration of treatment with UCMSCs-Sec.
- 3680: The page number of the news report in Health & Medicine Week, May 16, 2025.
- 2025: The year the study was published.
Sources:
- NewsRx. New Findings in Apoptosis Described from University of Lahore (Umbilical cord-derived secretome induces apoptosis and reduces proliferation in cancer cells). Health & Medicine Week. May 16, 2025; p 3680.
- Umbilical cord-derived secretome induces apoptosis and reduces proliferation in cancer cells. International Journal of Applied and Experimental Biology, 2025.